Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB518 in Advanced Gynecological Malignancies
NCT07448922Phase 2Recruiting
- Sponsor
- Kelun-Biotech
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of SKB518 in ovarian cancer, Cervical Cancer (CC), endometrial cancer (EC), sponsored by Kelun-Biotech. Started Apr 2026; status: recruiting.
02
Drugs
SKB518
03
Conditions
ovarian cancerCervical Cancer (CC)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT07448922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448922.